CannIntelligence open content

Why US DEA decision does not mean the end for cannabinoids

Written by Barnaby Page | 27th February 2023

FOR IMMEDIATE RELEASE Why US DEA decision does not mean the end for cannabinoids The US intoxicating hemp-derived cannabinoid (IHDC) market will not be ended by clarification from authorities saying delta-8 THC-O and delta-9 THC-O...

Cold-pressed CBD in the UK – exploiting an apparent loophole in novel food rules

Written by CannIntelligence | 22nd February 2023

Cold-pressed hemp oils appear to provide a way for CBD producers to circumvent UK rules on novel foods – but while some are all in favour, others see dangers and shortcomings ...

US DEA draws a ‘clear line in the sand’ on synthetically derived THCO acetates

Written by Tiziana Cauli | 21st February 2023

The US Drug Enforcement Administration (DEA) has clarified its position on two synthetic hemp derivatives, confirming that it considers delta-8 THCO and delta-9 THCO illegal ...

Another poll finds huge popular support for US legalisation – but who is listening?

Written by Freddie Dawson | 16th February 2023

Another poll weighted to be nationally representative of US voters has shown strong support for legalising adult use of recreational cannabis – and broad backing for including social equity measures ...

CBD brands apply for certification as Google lifts ads ban in some parts of US

Written by Tiziana Cauli | 10th February 2023

Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US ...

Could a smart rapper help smokable hemp seriously disrupt Big Tobacco?

Written by Freddie Dawson | 9th February 2023

Could the involvement of Snoop Dogg help a Californian companyt to “disrupt tobacco’s nearly $1tn industry with hemp cigarettes, smoking paper and other alternatives to nicotine tobacco”? ...

Mexican CBD retailer sets itself up as market leader ahead of regulations

Written by CannIntelligence | 3rd February 2023

Mexican CBD shop Paradise says it has placed itself in prime position for the creation of a legal recreational cannabis market in the country ...

If teenage cannabis use is rising, that has nothing to do with adult legalisation

Written by CannIntelligence | 2nd February 2023

While youth cannabis use is increasing in the US, contextual data show this trend is not associated with the creation of legal cannabis markets ...

Developing countries could get economic boost from industrial hemp, says UN

Written by Tiziana Cauli | 25th January 2023

Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status ...

How did we do? CannIntelligence’s 2022 predictions measured against events

Written by Freddie Dawson | 18th January 2023

CannIntelligence predicted that 2022 would be the year of intoxicating hemp-derived cannabinoids (IHDCs) and that has proven to be the case. But’s not been plain sailing for cannabis or CBD ...

Much-needed research into SCRAs’ huge medical potential faces high barriers

Written by Freddie Dawson | 12th January 2023

The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research ...

Colombia ready to lead Latin America into a more cannabis-friendly future

Written by CannIntelligence | 5th January 2023

CannIntelligence reviews developments in cannabis regulation in Latin America in 2022 and looks forward to likely further opening-up of the industry in many of the region's nations in 2023 ...

Of headaches, pirates and the rise in cannabis against tobacco smoking

Written by Aidan Semmens | 5th January 2023

Correlation is not causation, but it’s tempting to see a meaningful pattern in figures showing that US adults (particularly the younger ones) are smoking less tobacco and using more cannabis ...

Is 2023 the year for the great leap forward on cannabis regulation?

Written by Freddie Dawson | 3rd January 2023

Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It's possible ...

Pain, pot and placebos – flawed study fails to reveal their true relationship

Written by CannIntelligence | 22nd December 2022

Despite what its authors claim, a new and widely reported study fails to establish that the analgesic properties of cannabis can be largely attributable to the placebo effect ...

Advocates for psylocibin as therapeutic treatment push Canadian government

Written by CannIntelligence | 16th December 2022

Canadian advocates for therapeutic access to psilocybin are ramping up their efforts to get the federal government to grant exemptions to the country’s drug laws so patients and healthcare providers can legally access the drug...

Cannabis and dopamine – potential good news for bipolar disorder sufferers

Written by CannIntelligence | 13th December 2022

New research suggests that the effect of cannabis on dopamine may help to treat certain symptoms of bipolar disorder, with a reduced tendency to engage in risky behaviours and some improvement in cognitive ability ...

Simon the brand-builder demonstrates confidence in future of cannabis drinks

Written by Lorraine Mullaney | 7th December 2022

Cannabis-infused drinks have been the subject of industry debate and speculation as they raise many challenges – from regulatory hurdles to dosage issues and taste formulation – but is it just a case of "when",...

Canopy Growth restructures from the top to focus on ‘areas of greatest opportunity’

Written by CannIntelligence | 7th December 2022

One of Canada’s largest cannabis companies has announced plans to restructure in a bid to achieve profitability and set the stage for expansion into the US market ...

How will the midterm shift in the balance of power in Washington affect cannabis?

Written by CannIntelligence | 23rd November 2022

The predicted Red Wave never arrived – but how have the prospects for cannabis-related federal legislation in the US been changed by the midterm elections? US correspondent James DeLise considers the new balance of power...